How we treat mature B-cell neoplasms (indolent B-cell lymphomas)

Overview of attention for article published in Journal of Hematology & Oncology, January 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,546 followers.

How we treat mature B-cell neoplasms (indolent B-cell lymphomas) | Journal of Hematology & Oncology | Full Text https://t.co/kLsM4M2p4A

30 Jan 2022

Reply Repost Favourite

Our review of iNHL aims to provide oncologists with numeric data to support treatment decisions and share with patients... what is the rate and type of side effects with RT ? how long until response to novel drugs? how many will benefit from ASCT ? https:/

17 Jan 2021

Reply Repost Favourite

How we treat mature B-cell neoplasms (indolent B-cell lymphomas). #lymphoma #lymsm https://t.co/C7ZsTRlUda

08 Jan 2021

Reply Repost Favourite

New article: How we treat mature B-cell neoplasms (indolent B-cell lymphomas). https://t.co/IqJMC1b37a #FL #lymsm #hematology https://t.co/P05B6VOrf8

08 Jan 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.